Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H17NO4.ClH |
| Molecular Weight | 323.771 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.OC1=CC2=C(C=C1O)C(CC3=CC(O)=C(O)C=C3)NCC2
InChI
InChIKey=WSIHAFYVFLJCQH-UHFFFAOYSA-N
InChI=1S/C16H17NO4.ClH/c18-13-2-1-9(6-14(13)19)5-12-11-8-16(21)15(20)7-10(11)3-4-17-12;/h1-2,6-8,12,17-21H,3-5H2;1H
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis. | 2010-09 |
|
| The biosynthesis of papaverine proceeds via (S)-reticuline. | 2010-08 |
|
| Molecular characterization of O-methyltransferases involved in isoquinoline alkaloid biosynthesis in Coptis japonica. | 2010 |
|
| Computational systems analysis of dopamine metabolism. | 2008-06-18 |
|
| Chiral separation of norlaudanosoline, laudanosoline, laudanosine, chlorthalidone, and three benzoin derivatives using amino acid based molecular micelles. | 2006-02 |
|
| Human white blood cells synthesize morphine: CYP2D6 modulation. | 2005-12-01 |
|
| Mammalian morphine: de novo formation of morphine in human cells. | 2005-05 |
|
| Norlaudanosoline and nicotine increase endogenous ganglionic morphine levels: nicotine addiction. | 2005-04-26 |
|
| Analysis of benzylisoquinoline-type alkaloids by electrospray tandem mass spectrometry and atmospheric pressure photoionization. | 2005 |
|
| Aggravation of L-DOPA-induced neurotoxicity by tetrahydropapaveroline in PC12 cells. | 2003-11-01 |
|
| Purification and characterization of norcoclaurine synthase. The first committed enzyme in benzylisoquinoline alkaloid biosynthesis in plants. | 2002-09-13 |
|
| Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells. | 1994-03 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m10631
Created by
admin on Mon Mar 31 21:58:07 GMT 2025 , Edited by admin on Mon Mar 31 21:58:07 GMT 2025
|
PRIMARY | Merck Index | ||
|
NF7L11I15K
Created by
admin on Mon Mar 31 21:58:07 GMT 2025 , Edited by admin on Mon Mar 31 21:58:07 GMT 2025
|
PRIMARY | |||
|
3184-36-9
Created by
admin on Mon Mar 31 21:58:07 GMT 2025 , Edited by admin on Mon Mar 31 21:58:07 GMT 2025
|
PRIMARY | |||
|
DTXSID50953754
Created by
admin on Mon Mar 31 21:58:07 GMT 2025 , Edited by admin on Mon Mar 31 21:58:07 GMT 2025
|
PRIMARY | |||
|
18518
Created by
admin on Mon Mar 31 21:58:07 GMT 2025 , Edited by admin on Mon Mar 31 21:58:07 GMT 2025
|
PRIMARY | |||
|
221-680-7
Created by
admin on Mon Mar 31 21:58:07 GMT 2025 , Edited by admin on Mon Mar 31 21:58:07 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
